Mecasermin: all 34 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Gene Expression Changes In Young and Geriatric SkinRecruitingNCT03932162Early Phase 1
- IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 DeficiencyCompletedNCT02636270Phase 1/2Results posted
- Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)CompletedNCT02386839Phase 2Results posted
- A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum DisorderTerminatedNCT01970345Phase 2Results posted
- Treatment of Rett Syndrome With Recombinant Human IGF-1CompletedNCT01777542Phase 2Results posted
- Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)CompletedNCT01525901Phase 2Results posted
- IGF-1 and Bone Loss in Women With Anorexia NervosaCompletedNCT01406444Not applicableResults posted
- Effects of Anorexia Nervosa on Peak Bone MassCompletedNCT01301183Phase 3Results posted
- Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)CompletedNCT01253317Phase 1Results posted
- Safety and Efficacy Study of IGF-1 in Duchenne Muscular DystrophyCompletedNCT01207908Phase 1/2Results posted
- Effect of Increlex® on Children With Crohn DiseaseTerminatedNCT00764699Phase 2/3Results posted
- Effects of rhIGF-1 on Bone Metabolism in Adolescent Girls With Anorexia NervosaCompletedNCT00720122Phase 2Results posted
- Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk FactorsTerminatedNCT00684957Phase 1/2Results posted
- Assessment of Mechanisms of Improved Wound HealingCompletedNCT00673309Phase 2/3Results posted
- rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 DeficiencyTerminatedNCT00572156Phase 2Results posted
- Long-Term Treatment With rhIGF-1 in GHISCompletedNCT00571727Phase 2/3Results posted
- Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in AdolescentsCompletedNCT00516386Phase 1/2Results posted
- Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1TerminatedNCT00490100Phase 1/2Results posted
- Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 DeficiencyTerminatedNCT00330668Phase 3Results posted
- Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 DeficiencyCompletedNCT00125190Phase 2/3Results posted
- Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) DeficiencyCompletedNCT00125164Phase 3Results posted
- Patellar Tendinopathy - Effect of Training and Enhancement of the Collagen Synthesis by Insulin-like Growth Factor-IStatus unknownNCT01834989Early Phase 1
- IGF-I Induced Muscle Glucose Uptake and Interstitial IGF-I ConcentrationsCompletedNCT01588093Not applicable
- IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos PatientsCompletedNCT01446783Not applicable
- Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart AttackCompletedNCT01438086Phase 1/2
- Effects of IGF-I in HIV Metabolic DiseaseTerminatedNCT01329744Phase 1
- Increlex Treatment of Children With Chronic Liver Disease and Short StatureWithdrawnNCT01314508Not applicable
- Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)CompletedNCT01020955Phase 3
- IGF-1 Therapy in Patients With Cystic FibrosisTerminatedNCT00566241Phase 1
- Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan SyndromeTerminatedNCT00351221Phase 2
- Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With HyperinsulinismCompletedNCT00004700Phase 2
- Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With HyperinsulinismCompletedNCT00004699Not applicable
- Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin ResistanceCompletedNCT00004419Not applicable
- A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) PatientsCompletedNCT00001669Phase 2